MHRA approves two new medicines for overactive bladder syndrome and breast cancer
Pierre Fabre Limited receives MHRA marketing authorisation for vibegron, Astra Zeneca UK Limited for Capivasertib
The Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday,...
Dr. Reddy’s Teraleve® Fesoterodine Fumarate Prolonged-Release tablets for incontinence
Dr. Reddy’s Teraleve ® 4mg and 8mg Fesoterodine Fumarate Prolonged-Release tablets have been available in the UK since their launch on 1st June 2022.
Therapeutic...